about
Chemical Communication between Heart Cells is Disrupted by Intracellular Renin and Angiotensin II: Implications for Heart Development and DiseaseAge-Related Macular Degeneration and Intracrine Biology: An HypothesisDistribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brainsThe physiological basis of intracrine stem cell regulation.Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callusHigh molecular weight isoforms of growth hormone in cells of the immune systemThe mitochondrial component of intracrine action.Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine actionC-terminal processing of GABARAP is not required for trafficking of the angiotensin II type 1A receptor.Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle.Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.Thirty years of intracrinology.Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.Intracrine action of angiotensin II in the intact ventricle of the failing heart: angiotensin II changes cardiac excitability from within.A Pathogenic Mechanism Potentially Operative in Multiple Progressive Diseases and Its Therapeutic Implications.
P2860
Q27690732-E741444C-3241-4ED2-9F18-9853A45C24B3Q28072590-D8D87192-B920-4596-92F7-FF670306D521Q34078729-839974DB-61C5-48F4-9F8F-97C336DC517BQ36844618-0993E2A5-4F93-48BE-827F-F0A20B06889AQ37034753-5E980100-497B-4D0E-A337-569697B7B62EQ37115030-13EBFD50-5E16-4833-9C9F-40FFC56FB11BQ37174249-DEDAB586-077E-462E-AFE9-A973FF450694Q37372370-928A748F-D6B3-464B-90B2-009FFFFDE2BEQ37479907-3528B68A-E7C0-4D5B-830A-AC3AC157666CQ37546233-ABEB2DD4-85F4-412C-A0A9-C115B8C2DA18Q37592161-B8435B96-B75C-48B5-A135-26491968802BQ37660786-364A86EB-59E2-4F2B-AC54-8170A558F809Q38322924-24EBE717-373F-4646-8358-29C0EEDAD9DBQ42170122-D735C19C-B5A6-4A68-8576-A3A3755651BFQ42647621-CE2428D8-2A0E-4D77-93C0-2ECE93D52712Q47835909-0C775D36-60A9-44FF-B4F8-07026BE90DD0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The basis of an intracrine pharmacology.
@en
The basis of an intracrine pharmacology.
@nl
type
label
The basis of an intracrine pharmacology.
@en
The basis of an intracrine pharmacology.
@nl
prefLabel
The basis of an intracrine pharmacology.
@en
The basis of an intracrine pharmacology.
@nl
P2860
P356
P1476
The basis of an intracrine pharmacology.
@en
P2093
Julia L Cook
Richard N Re
P2860
P304
P356
10.1177/0091270007312155
P577
2008-01-25T00:00:00Z